Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The projected fair value for Henry Schein is US$67.04 based on 2 Stage Free Cash Flow to Equity With US$70.70 share price, Henry Schein appears to be trading close to its estimated fair value ...

Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...

Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Henry Schein (NasdaqGS:HSIC) from ...

Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic ...

BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...

Dental and medical professionals who may experience operational, logistical, or financial issues are encouraged to call 800-999-9729 ...

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust acquisition strategy helps it to ...

As previously reported, BofA analyst Allen Lutz upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69, ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that ...

Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental practitioners, laboratories, physician practices, ambulatory surgery centers ...

NAW said Henry Schein’s CEO won the award for his leadership, service and engagement with the association and distribution ...